Titel: Moral and Ethical Imperatives of Health Care Technologies: Scientific, legal and socioeconomic perspectives on use and misuse
Termin:
6.12.2007
Veranstaltungsort:
Convention Centre
National Institute of Mental Health and Neurosciences
Bangalore, Karnataka
India
Weitere Informationen:
http://ijme.in/2nbcbrochure.pdf
The second NBC will be held on the 6, 7 and 8 December 2007
CONFERENCE THEME AND SUB-THEMES
Developments in technology have been crucial in shaping health care all over the world. In view of the importance of health care technologies, and the social, economic, legal and moral dimensions that shape their development, use and misuse, this will be the theme of the second NBC 2007. The Conference aims to facilitate comprehensive debates and dialogues on health care technologies in the contexts of clinical practice, research, and public health and policy.
Sub-theme: Technologies in medical practice
Medical technologies dominate present-day clinical practice. While they are essential for quality of care they also affect the costs of health care, peoples access to care, and the relationship between the practitioners and manufacturers of these technologies.
A number of ethical issues have arisen in the use of technologies to prolong life, such as organ transplantation; technologies for artificial reproduction which has eugenic possibilities; those for genetic screening, stem cell therapy, and so on.
Sub-theme: Research on health care technologies
Research on health care technologies has been a hotly debated subject in bioethics. This is particularly so in fields such as vaccine and drug development, genomics, artificial reproduction and stem cell research. The explosion of research activity has led to the development of new arrangements for conducting health research in different parts of the world. The growth of contract research organisations and the outsourcing of trials have raised several questions about research oversight and mechanisms for demanding accountability from dispersed and often unrelated stakeholders.
Discussions on this sub-theme also include priority setting for research; the participation (or exclusion) of vulnerable groups; benefits and undue inducements; risk-benefit analysis; the quality of informed consent; injury compensation; standard of care; post-trial benefits; patents and intellectual property rights; and the competence and functioning of Institutional Ethics Committees.
Sub-theme: Health care technologies, public health and policies
Any technology, when used on a wide scale, has important consequences for society. This is particularly evident in the case of food and agricultural technology. Large numbers of people all over the world still suffer from malnutrition. Another example of the profound impact of technology on human society is in the development and deployment of vaccines.
While technology has vastly expanded the range of health care options, it has also led to a massive increase in the cost of health care. Prohibitive costs have made access to health care difficult for many and led to indebtedness and further exacerbation of poverty. Paradoxically, the growth of medical technology has levelled international barriers, encouraging medical tourism. The superimposition of a highly modernised health care system on societies where primary care remains a pressing need is fraught with ethical dilemmas.
Ethical issues also emerge at the intersections of policies on trade and health. For example, intellectual property rights, compulsory licensing, and international trade agreements have had important implications for drug pricing and access in developing countries. The balancing of economic and health concerns merits close attention.
Kontakt:
Mr. Abraham Thomas
C/O IIMB-Samata Project
#42, 1st Floor, Muniga Layout
Banaswadi Main Rd
Bangalore 560 033
India
Tel.:
+91 - 80 - 25 80 25 63
Fax: +91 - 80 - 25 80 25 63
nbc.ijme@gmail.com
http://nbc.ijme.in/
Veranstalter: Indian Journal of Medical Ethics
Schlagworte: Embryonale Stammzellen, Ethik-Kommissionen, Eugenik/Enhancement, Fortpflanzungsmedizin, Genetische Tests/Beratung, Genforschung/-technik, Gesundheitswesen, Medizinische Ethik, Organ-/Gewebetransplantation, Pharmazeutik